アドシルカ錠２０ｍｇ
基本情報
| 項目 | 値 |
|---|---|
| DrugBank ID | DB00820 |
| エビデンスレベル | L5（計算予測のみ） |
| 予測適応症数 | 44 |
| 日本商品名（例） | アドシルカ錠２０ｍｇ, アドシルカ錠２０ｍｇ（選）, ザルティア錠２．５ｍｇ |
承認適応症（KEGG）
肺動脈性肺高血圧症
予測適応症（TxGNN）
以下は TxGNN モデルにより予測された潜在的新適応症です。スコアが高いほど関連性が高いと予測されています。
| # | 適応症 | スコア | ソース |
|---|---|---|---|
| 1 | benign prostatic hyperplasia (disease) | 99% | DL |
| 2 | Ambras type hypertrichosis universalis congenita | 99% | DL |
| 3 | hypertrichosis (disease) | 99% | DL |
| 4 | malformation syndrome with odontal and/or periodontal component | 99% | DL |
| 5 | syndrome with a Dandy-Walker malformation as major feature | 99% | DL |
| 6 | isolated genetic hair shaft abnormality | 99% | DL |
| 7 | familial isolated trichomegaly | 99% | DL |
| 8 | pulmonary hypertension | 99% | DL |
| 9 | kyphoscoliotic heart disease | 99% | DL |
| 10 | migraine with brainstem aura | 99% | DL |
| 11 | migraine disorder | 98% | DL |
| 12 | hypotrichosis simplex of the scalp | 98% | DL |
| 13 | Raynaud disease | 98% | DL |
| 14 | congenital hypotrichosis milia | 98% | DL |
| 15 | alopecia | 98% | DL |
| 16 | diffuse alopecia areata | 98% | DL |
| 17 | genetic alopecia | 98% | DL |
| 18 | familial clubfoot due to 17q23.1q23.2 microduplication | 97% | DL |
| 19 | obsolete patella aplasia, coxa vara, and tarsal synostosis | 97% | DL |
| 20 | pulmonary hypertension, primary, autosomal recessive | 97% | DL |
| 21 | prostate calculus | 97% | DL |
| 22 | obsolete susceptibility to ischemic stroke | 97% | DL |
| 23 | pseudopelade of Brocq | 97% | DL |
| 24 | 16q24.1 microdeletion syndrome | 97% | DL |
| 25 | isolated pulmonary capillaritis | 97% | DL |
| 26 | primary interstitial lung disease specific to childhood | 97% | DL |
| 27 | coxopodopatellar syndrome | 97% | DL |
| 28 | chromosome 17q23.1-q23.2 deletion syndrome | 97% | DL |
| 29 | hypoalphalipoproteinemia | 96% | DL |
| 30 | congenital pulmonary lymphangiectasia | 96% | DL |
| 31 | cerebrovascular disorder | 96% | DL |
| 32 | amenorrhea (disease) | 94% | DL |
| 33 | congenital alveolar capillary dysplasia | 94% | DL |
| 34 | stroke disorder | 94% | DL |
| 35 | cor pulmonale | 94% | DL |
| 36 | spinal cord ischemia | 93% | DL |
| 37 | ABri amyloidosis | 92% | DL |
| 38 | pulmonary hypertension, primary | 92% | DL |
| 39 | idiopathic pulmonary arterial hypertension | 91% | DL |
| 40 | peripheral vascular disease | 90% | DL |
| 41 | pulmonary arterial hypertension | 90% | DL |
| 42 | erectile dysfunction (disease) | 63% | DL |
| 43 | premature ejaculation (disease) | 6% | DL |
| 44 | psychologic dyspareunia | 4% | DL |
免責事項
これらの予測は研究目的のみであり、医療アドバイスを構成するものではありません。 臨床応用には必ず適切な検証が必要です。